Repurposing an FDA-Approved Drug to Inhibit Bacterial Protein Toxins

被引：0
|
作者：
Borho, J. [1 ]
Eckert, A. [1 ]
Koegel, M. [1 ]
Barth, H. [1 ]
机构：
[1] Univ Ulm Med Ctr, Inst Expt & Clin Pharmacol, Toxicol & Pharmacol Nat Prod, Ulm, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2024年 / 397卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P061
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [41] Repurposing of FDA-approved lead drugs as potentiators of uterine contractility in postpartum hemorrhage
    Iwueke, Chisom C.
    Hansen, Christopher J.
    Siricilla, Shajila
    Herington, Jennifer L.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S325 - S325
  • [42] Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer
    Moraca, Federica
    Arciuolo, Valentina
    Marzano, Simona
    Napolitano, Fabiana
    Castellano, Giuliano
    D'Aria, Federica
    Di Porzio, Anna
    Landolfi, Laura
    Catalanotti, Bruno
    Randazzo, Antonio
    Pagano, Bruno
    Malfitano, Anna Maria
    Amato, Jussara
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 285
  • [43] QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
    Paul G. O’Reilly
    Qing Wen
    Peter Bankhead
    Philip D. Dunne
    Darragh G. McArt
    Suzanne McPherson
    Peter W. Hamilton
    Ken I. Mills
    Shu-Dong Zhang
    BMC Bioinformatics, 17
  • [44] Repurposing of FDA-approved Therapeutics to Identify Novel Radiosensitisers in Hypoxic Prostate Cancer
    Thiruthaneeswaran, N.
    Bibby, B. A. S.
    Yang, L.
    McArt, D.
    Choudhury, A.
    West, C.
    CLINICAL ONCOLOGY, 2018, 30 (03) : 195 - 196
  • [45] QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
    O'Reilly, Paul G.
    Wen, Qing
    Bankhead, Peter
    Dunne, Philip D.
    McArt, Darragh G.
    McPherson, Suzanne
    Hamilton, Peter W.
    Mills, Ken I.
    Zhang, Shu-Dong
    BMC BIOINFORMATICS, 2016, 17
  • [46] Impact of Nutrition or FDA-Approved Medicine Repurposing on Metabolic Syndrome and Diabetic Complications
    Cai, Lu
    NUTRIENTS, 2023, 15 (11)
  • [47] Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease
    Cannon, Matthew
    Phillips, Hannah
    Smith, Sidney
    Williams, Katie
    Brinton, Lindsey
    Gregory, Charles
    Landes, Kristina
    Desai, Payal
    Byrd, John
    Lapalombella, Rosa
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 14
  • [48] In Silico Drug Repurposing Approach: Investigation of Mycobacterium tuberculosis FadD32 Targeted by FDA-Approved Drugs
    Ngidi, Nolwazi Thobeka Portia
    Machaba, Kgothatso Eugene
    Mhlongo, Ndumiso Nhlakanipho
    MOLECULES, 2022, 27 (03):
  • [49] FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes
    de Poel, E.
    Spelier, S.
    Hagemeijer, M. C.
    van Mourik, P.
    Suen, S. W. F.
    Vonk, A. M.
    Brunsveld, J. E.
    Ithakisiou, G. N.
    Kruisselbrink, E.
    Oppelaar, H.
    Berkers, G.
    de Groot, K. M. de Winter
    Heida-Michel, S.
    Jans, S. R.
    van Panhuis, H.
    Bakker, M.
    van der Meer, R.
    Roukema, J.
    Dompeling, E.
    Weersink, E. J. M.
    Koppelman, G. H.
    Blaazer, A. R.
    Muijlwijk-Koezen, J. E.
    van der Ent, C. K.
    Beekman, J. M.
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (03) : 548 - 559
  • [50] THPdb: Database of FDA-approved peptide and protein therapeutics
    Usmani, Salman Sadullah
    Bedi, Gursimran
    Samuel, Jesse S.
    Singh, Sandeep
    Kalra, Sourav
    Kumar, Pawan
    Ahuja, Anjuman Arora
    Sharma, Meenu
    Gautam, Ankur
    Raghava, Gajendra P. S.
    PLOS ONE, 2017, 12 (07):
12345